Sign in

You're signed outSign in or to get full access.

Sandra L. Yeager

About Sandra L. Yeager

Independent Director nominee (year of birth: 1964) serving on the Board since June 2020, with over 26 years in investment management including CIO/President roles and global research leadership; current status: retired. Committee assignments: Audit (Chair), Contracts, and Investment Review, with confirmation that all independent Director incumbents attended at least 75% of Board and relevant committee meetings in 2024. The Board met 5 times in 2024; Audit Committee members are NYSE “independent.”

Past Roles

OrganizationRoleTenureCommittees/Impact
Hanoverian Capital, LLCPresident & Founder; CIO of SEC-registered investment adviser specializing in international equities2008–2016Built and led the firm; senior investment decision maker
DuPont CapitalManaging Director; Head of International Equities2006–2008Led international equity investment function
Morgan Stanley Investment ManagementManaging Director; Head of Global Equity Research2004–2006Led a team of ~30 professionals; global research oversight
AllianceBernsteinSenior Vice President; Equity Analyst → Global Portfolio Manager1990–2004Progressed from research to portfolio management for institutional and mutual fund clients

External Roles

OrganizationRoleTenureNotes
NAPE Education FoundationDirectorOct 2016–Oct 2020Non-profit board service
Jennersville YMCAAdvisory BoardJun 2022–Jun 2023Community/non-profit advisory role

Board Governance

  • Committee memberships: Audit (Chair), Contracts, Investment Review; all standing committees comprise solely Independent Directors.
  • Audit Committee independence: Members are “independent” under NYSE listing standards; committee charter updated March 2024.
  • Audit Committee composition: Sandra L. Yeager (Chair), Brian J. Gallagher, Patricia M. Flynn, Douglas A. Hacker, David M. Moffett.
  • Meeting cadence (2024): Board (5), Audit (6), Board Governance (6), Compliance (4), Contracts (5), Investment Review (4).
  • Attendance: Each incumbent Director attended at least 75% of Board and relevant committee meetings held in 2024.
  • Pre-approval authority: For permitted services requiring pre-approval outside regular meetings, authority is delegated to Ms. Yeager (Audit Committee Chair); de minimis non-audit services may be exempt from pre-approval.
  • Independence status: Listed as Independent Director nominee; chair roles limited to independent committees.

Fixed Compensation

ComponentAmount/StructurePeriodSource
Aggregate direct remuneration paid by STK to all independent Directors$36,193FY2024
Ms. Yeager – Aggregate compensation from STK$3,619FY2024
Ms. Yeager – Deferred portion (Fund-level)$1,810FY2024
Ms. Yeager – Total compensation from STK + Columbia Funds Complex$448,000FY2024
Pension/retirement benefits (Fund expenses)$0FY2024
2025 Independent Director cash retainer (non-Chair; complex-wide)$275,000 annualEffective Jan 1, 2025
Committee Chair retainer (complex-wide)+$25,000 annualEffective Jan 1, 2025
Sub-committee Chair retainer (complex-wide)+$15,000 annualEffective Jan 1, 2025
Board meeting fee (in-person)$6,000/dayEffective Jan 1, 2025
Committee/sub-committee meeting fee (in-person, separate day)$3,000/dayEffective Jan 1, 2025
Special virtual meeting fee$3,000/meetingEffective Jan 1, 2025
Closed-End Funds annual fee (Fund + one other)$10,000Ongoing
Board Chair total cash compensation$575,000 (+$10,000 from Closed-End Funds; +$3,000 special virtual meetings)Effective Jan 1, 2025

Deferred Compensation Plan: Independent Directors may defer up to 100% of compensation; balances are notionally invested in eligible Columbia Funds and distributed per election; plan is unfunded for tax purposes.

Performance Compensation

ElementDisclosureNotes
Performance-based bonusesNot disclosed/applicableIndependent Directors are compensated via retainers and meeting fees; no performance bonuses indicated.
Stock awards (RSUs/PSUs)Not disclosedNo equity grants for Directors noted; compensation is cash-based with optional deferral.
OptionsNot disclosedNo option awards disclosed.
Performance metrics tied to pay (e.g., TSR, EBITDA)Not disclosed/applicableNo performance linkage indicated for independent Director compensation.

Other Directorships & Interlocks

Company/EntityTypeRolePotential Interlock/Conflict
None disclosed (public companies)No public-company boards listed for Ms. Yeager in past five years.
NAPE Education FoundationNon-profitDirector (2016–2020)No STK-related transaction disclosed.
Jennersville YMCANon-profitAdvisory Board (2022–2023)No STK-related transaction disclosed.

Expertise & Qualifications

  • Investment leadership: Founded and ran Hanoverian Capital; Head of International Equities at DuPont Capital; Head of Global Equity Research at Morgan Stanley IM; AllianceBernstein global portfolio manager—strong buy-side and research credentials.
  • Team leadership: Led ~30-person global research team at Morgan Stanley IM; long-tenured progression from analyst to PM.
  • Sector breadth: Extensive global equities experience relevant to technology-focused investment mandates.
  • Education: Not disclosed.

Equity Ownership

MetricValue/RangeDateNotes
Beneficial ownership in STK$10,001–$50,000As of Dec 31, 2024Dollar-range only; share count not disclosed.
Aggregate beneficial ownership across Columbia Funds ComplexOver $100,000As of Dec 31, 2024Includes value of deferred compensation balances per plan elections.
Shares pledged as collateralNot disclosedNo pledging disclosure for Ms. Yeager.
Directors & officers (group) ownership of STK<1% of common shares outstandingAs of Dec 31, 2024Group-level; individual % not disclosed.
STK shares outstanding (for context)17,268,774Record date Apr 29, 2025Used to contextualize ownership ranges.
Deferred compensation election (Fund-level)$1,810 deferredFY2024Ms. Yeager elected to defer a portion of compensation.

Governance Assessment

  • Strengths: Independent Director with deep investment leadership experience; Audit Committee Chair with delegated pre-approval authority, signaling high engagement in audit quality and independence oversight; attendance threshold met; committee structure entirely independent.
  • Compensation alignment: Cash-based retainers and meeting fees with optional deferral into Columbia Funds create modest alignment via exposure to fund performance; beneficial ownership in STK within $10,001–$50,000 range and aggregate complex exposure >$100,000.
  • Potential risk indicators: Audit Committee permits de minimis exceptions to pre-approval of non-audit services (standard practice, but worth monitoring); significant audit-related services to affiliates ($590,000 in 2023 and 2024) are pre-approved—oversight depends on committee rigor.
  • Conflicts/related-party exposure: No related-party transactions, loans, or pledging disclosed for Ms. Yeager; committee roles are within independent committees; no public-company interlocks identified.

RED FLAGS: None explicitly disclosed for Ms. Yeager (no pledging, related-party transactions, legal proceedings, or attendance issues). Monitor continuing pre-approval processes for non-audit/affiliate services to ensure auditor independence remains robust.